The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA2325183
Max Phase: Preclinical
Molecular Formula: C15H12N4O2S
Molecular Weight: 312.35
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: O=C(NCC(=O)c1ccccc1)Nc1ccc2nnsc2c1
Standard InChI: InChI=1S/C15H12N4O2S/c20-13(10-4-2-1-3-5-10)9-16-15(21)17-11-6-7-12-14(8-11)22-19-18-12/h1-8H,9H2,(H2,16,17,21)
Standard InChI Key: PKHSKYFMULMNOC-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 312.35Molecular Weight (Monoisotopic): 312.0681AlogP: 2.70#Rotatable Bonds: 4Polar Surface Area: 83.98Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: 13.06CX Basic pKa: CX LogP: 2.40CX LogD: 2.40Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.73Np Likeness Score: -1.96
References 1. Liu F, Li F, Ma A, Dobrovetsky E, Dong A, Gao C, Korboukh I, Liu J, Smil D, Brown PJ, Frye SV, Arrowsmith CH, Schapira M, Vedadi M, Jin J.. (2013) Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors., 56 (5): [PMID:23445220 ] [10.1021/jm3018332 ]